US Bancorp’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-600	Closed	-$6K	–	3864
2020 Q3	$6K	Hold	600	–	–	﹤0.01%	3216
2020 Q2	$9K	Hold	600	–	–	﹤0.01%	3081
2020 Q1	$7K	Buy	+600	New	+$7K	﹤0.01%	3098